For my initial coverage of Labcorp, I'm calling it a hold, and an opportunity to earn a $0.72/share quarterly dividend on the leading clinical lab company in the US. The firm shows future growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results